These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2981265)

  • 1. Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM.
    Kris RM; Asofsky R; Evans CB; Small PA
    J Immunol; 1985 Feb; 134(2):1230-5. PubMed ID: 2981265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity.
    Liew FY; Russell SM; Appleyard G; Brand CM; Beale J
    Eur J Immunol; 1984 Apr; 14(4):350-6. PubMed ID: 6609824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.
    Tamura S; Funato H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
    Eur J Immunol; 1991 Jun; 21(6):1337-44. PubMed ID: 1646112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "sho-seiryu-to"--stimulation of mucosal immune system and effect on allergic pulmonary inflammation model mice.
    Nagai T; Yamada H
    Immunopharmacol Immunotoxicol; 1998 May; 20(2):267-81. PubMed ID: 9653672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive transfer of local immunity to influenza virus infection by IgA antibody.
    Renegar KB; Small PA
    J Immunol; 1991 Mar; 146(6):1972-8. PubMed ID: 2005388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.
    Renegar KB; Small PA; Boykins LG; Wright PF
    J Immunol; 2004 Aug; 173(3):1978-86. PubMed ID: 15265932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production.
    Iwasaki T; Nozima T
    J Immunol; 1977 Jan; 118(1):256-63. PubMed ID: 401512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal-infant transfer of influenza-specific immunity not detectable by haemagglutination inhibition.
    Reuman PD; Kris RM; Ayoub EM; Small PA
    Microbios; 1988; 54(220-221):135-47. PubMed ID: 2846987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immunity to influenza without IgA: an IgA knockout mouse model.
    Mbawuike IN; Pacheco S; Acuna CL; Switzer KC; Zhang Y; Harriman GR
    J Immunol; 1999 Mar; 162(5):2530-7. PubMed ID: 10072492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal-infant transfer of influenza-specific immunity in the mouse.
    Reuman PD; Paganini CM; Ayoub EM; Small PA
    J Immunol; 1983 Feb; 130(2):932-6. PubMed ID: 6848601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced protection against respiratory influenza A infection in mice by liposome-encapsulated antibody.
    Wong JP; Stadnyk LL; Saravolac EG
    Immunology; 1994 Feb; 81(2):280-4. PubMed ID: 8157277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive serum antibody causes temporary recovery from influenza virus infection of the nose, trachea and lung of nude mice.
    Kris RM; Yetter RA; Cogliano R; Ramphal R; Small PA
    Immunology; 1988 Mar; 63(3):349-53. PubMed ID: 2832312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.
    Tamura S; Miyata K; Matsuo K; Asanuma H; Takahashi H; Nakajima K; Suzuki Y; Aizawa C; Kurata T
    J Immunol; 1996 May; 156(10):3892-900. PubMed ID: 8621928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
    Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
    J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cell mediated immunity in influenza virus infection in mice.
    Schulman JL; Petigrow C; Woodruff J
    Dev Biol Stand; 1977 Jun 1-3; 39():385-90. PubMed ID: 304820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterotypic protective immune reactions in mice infected with distinct serotypes of human influenza virus.
    Floc'h F; Werner GH
    Ann Microbiol (Paris); 1978; 129(4):509-24. PubMed ID: 308787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of IgM antibodies versus B cells in influenza virus-specific immunity.
    Kopf M; Brombacher F; Bachmann MF
    Eur J Immunol; 2002 Aug; 32(8):2229-36. PubMed ID: 12209635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of antibody and complement in serum after challenge of mice previously vaccinated or infected with influenza virus.
    Semkow R; Wilczyński J
    Acta Virol; 1979 May; 23(3):253-6. PubMed ID: 41439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus.
    Asahi-Ozaki Y; Yoshikawa T; Iwakura Y; Suzuki Y; Tamura S; Kurata T; Sata T
    J Med Virol; 2004 Oct; 74(2):328-35. PubMed ID: 15332283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.